Literature DB >> 11964162

Chicken avidin-related proteins show altered biotin-binding and physico-chemical properties as compared with avidin.

Olli H Laitinen1, Vesa P Hytönen, Mervi K Ahlroth, Olli T Pentikäinen, Ciara Gallagher, Henri R Nordlund, Vladimir Ovod, Ari T Marttila, Eevaleena Porkka, Sanna Heino, Mark S Johnson, Kari J Airenne, Markku S Kulomaa.   

Abstract

Chicken avidin and bacterial streptavidin are proteins familiar from their use in various (strept)avidin-biotin technological applications. Avidin binds the vitamin biotin with the highest affinity known for non-covalent interactions found in nature. The gene encoding avidin (AVD) has homologues in chicken, named avidin-related genes (AVRs). In the present study we used the AVR genes to produce recombinant AVR proteins (AVRs 1, 2, 3, 4/5, 6 and 7) in insect cell cultures and characterized their biotin-binding affinity and biochemical properties. Amino acid sequence analysis and molecular modelling were also used to predict and explain the properties of the AVRs. We found that the AVR proteins are very similar to avidin, both structurally and functionally. Despite the numerous amino acid substitutions in the subunit interface regions, the AVRs form extremely stable tetramers similar to those of avidin. Differences were found in some physico-chemical properties of the AVRs as compared with avidin, including lowered pI, increased glycosylation and, most notably, reversible biotin binding for two AVRs (AVR1 and AVR2). Molecular modelling showed how the replacement Lys(111)-->isoleucine in AVR2 alters the shape of the biotin-binding pocket and thus results in reversible binding. Both modelling and biochemical analyses showed that disulphide bonds can form and link monomers in AVR4/5, a property not found in avidin. These, together with the other properties of the AVRs described in the present paper, may offer advantages over avidin and streptavidin, making the AVRs applicable for improved avidin-biotin technological applications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964162      PMCID: PMC1222514          DOI: 10.1042/0264-6021:3630609

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Sequence features and evolutionary mechanisms in the chicken avidin gene family.

Authors:  M K Ahlroth; A Grapputo; O H Laitinen; M S Kulomaa
Journal:  Biochem Biophys Res Commun       Date:  2001-07-20       Impact factor: 3.575

2.  Copy-number fluctuation by unequal crossing-over in the chicken avidin gene family.

Authors:  M K Ahlroth; P Ahlroth; M S Kulomaa
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

3.  Avidin.

Authors:  N M Green
Journal:  Adv Protein Chem       Date:  1975

4.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  Egg white avidin. 3. Sequence of the 78-residue middle cyanogen bromide peptide. Complete amino acid sequence of the protein subunit.

Authors:  R J DeLange; T S Huang
Journal:  J Biol Chem       Date:  1971-02-10       Impact factor: 5.157

6.  Molecular cloning of the chicken avidin cDNA.

Authors:  M L Gope; R A Keinänen; P A Kristo; O M Conneely; W G Beattie; T Zarucki-Schulz; B W O'Malley; M S Kulomaa
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

7.  Extremely high thermal stability of streptavidin and avidin upon biotin binding.

Authors:  M González; C E Argaraña; G D Fidelio
Journal:  Biomol Eng       Date:  1999-12-31

8.  Biotin induces tetramerization of a recombinant monomeric avidin. A model for protein-protein interactions.

Authors:  O H Laitinen; A T Marttila; K J Airenne; T Kulik; O Livnah; E A Bayer; M Wilchek; M S Kulomaa
Journal:  J Biol Chem       Date:  2000-11-13       Impact factor: 5.157

9.  Engineering of chicken avidin: a progressive series of reduced charge mutants.

Authors:  A T Marttila; K J Airenne; O H Laitinen; T Kulik; E A Bayer; M Wilchek; M S Kulomaa
Journal:  FEBS Lett       Date:  1998-12-18       Impact factor: 4.124

10.  Avidin expression during chick chondrocyte and myoblast development in vitro and in vivo: regulation of cell proliferation.

Authors:  B Zerega; L Camardella; S Cermelli; R Sala; R Cancedda; F Descalzi Cancedda
Journal:  J Cell Sci       Date:  2001-04       Impact factor: 5.285

View more
  14 in total

1.  Tetravalent single-chain avidin: from subunits to protein domains via circularly permuted avidins.

Authors:  Henri R Nordlund; Vesa P Hytönen; Jarno Hörhä; Juha A E Määttä; Daniel J White; Katrin Halling; Eevaleena J Porkka; J Peter Slotte; Olli H Laitinen; Markku S Kulomaa
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

2.  Efficient production of active chicken avidin using a bacterial signal peptide in Escherichia coli.

Authors:  Vesa P Hytönen; Olli H Laitinen; Tomi T Airenne; Heidi Kidron; Niko J Meltola; Eevaleena J Porkka; Jarno Hörhä; Tiina Paldanius; Juha A E Määttä; Henri R Nordlund; Mark S Johnson; Tiina A Salminen; Kari J Airenne; Seppo Ylä-Herttuala; Markku S Kulomaa
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

3.  Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment.

Authors:  Vesa P Hytönen; Olli H Laitinen; Alessandro Grapputo; Anu Kettunen; Janne Savolainen; Nisse Kalkkinen; Ari T Marttila; Henri R Nordlund; Thomas K M Nyholm; Giovanni Paganelli; Markku S Kulomaa
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

4.  Construction of chimeric dual-chain avidin by tandem fusion of the related avidins.

Authors:  Tiina A Riihimäki; Sampo Kukkurainen; Suvi Varjonen; Jarno Hörhä; Thomas K M Nyholm; Markku S Kulomaa; Vesa P Hytönen
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

5.  Avidin related protein 2 shows unique structural and functional features among the avidin protein family.

Authors:  Vesa P Hytönen; Juha A E Määttä; Heidi Kidron; Katrin K Halling; Jarno Hörhä; Tuomas Kulomaa; Thomas K M Nyholm; Mark S Johnson; Tiina A Salminen; Markku S Kulomaa; Tomi T Airenne
Journal:  BMC Biotechnol       Date:  2005-10-07       Impact factor: 2.563

6.  A multipurpose vector system for the screening of libraries in bacteria, insect and mammalian cells and expression in vivo.

Authors:  Olli H Laitinen; Kari J Airenne; Vesa P Hytönen; Erik Peltomaa; Anssi J Mähönen; Thomas Wirth; Miia M Lind; Kari A Mäkelä; Pyry I Toivanen; Diana Schenkwein; Tommi Heikura; Henri R Nordlund; Markku S Kulomaa; Seppo Ylä-Herttuala
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

7.  Structural and functional characteristics of xenavidin, the first frog avidin from Xenopus tropicalis.

Authors:  Juha A E Määttä; Satu H Helppolainen; Vesa P Hytönen; Mark S Johnson; Markku S Kulomaa; Tomi T Airenne; Henri R Nordlund
Journal:  BMC Struct Biol       Date:  2009-09-29

8.  Structure of bradavidin-C-terminal residues act as intrinsic ligands.

Authors:  Jenni Leppiniemi; Toni Grönroos; Juha A E Määttä; Mark S Johnson; Markku S Kulomaa; Vesa P Hytönen; Tomi T Airenne
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

9.  A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells.

Authors:  Hanna-Riikka Kärkkäinen; Hanna P Lesch; Antti I Määttä; Pyry I Toivanen; Anssi J Mähönen; Miia M Roschier; Kari J Airenne; Olli H Laitinen; Seppo Ylä-Herttuala
Journal:  BMC Res Notes       Date:  2009-04-23

10.  Structure and characterization of a novel chicken biotin-binding protein A (BBP-A).

Authors:  Vesa P Hytönen; Juha A E Määttä; Einari A Niskanen; Juhani Huuskonen; Kaisa J Helttunen; Katrin K Halling; Henri R Nordlund; Kari Rissanen; Mark S Johnson; Tiina A Salminen; Markku S Kulomaa; Olli H Laitinen; Tomi T Airenne
Journal:  BMC Struct Biol       Date:  2007-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.